HIV post-exposure prophylaxis: enhancing its pharmaco-economic profile by discriminate prescribing

J. Postma, Maarten; M Bos, Jasper; T.W. de Jong‐van den Berg, Lolkje; Tramarin, Andrea; van Bergen, Jan

doi:10.1097/00002030-200205240-00012

Public

HIV post-exposure prophylaxis: enhancing its pharmaco-economic profile by discriminate prescribing

Published in AIDS • May 1, 2002

Authors:

Maarten J. Postma

Jasper M Bos

Lolkje T.W. de Jong‐van den Berg

Abstract

In this issue, Greub et al. show that discriminate prescribing and utilization of HIV post-exposure prophylaxis (PEP) is sensible from a pharmaco-economic point of view [1]. They investigate a policy of active approaching and HIV-testing of source persons after non-occupational HIV exposures (sexual...

Subject

Medicine

Cost–benefit analysis

Zidovudine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!